IP Library › Granted Patent US 7,482,426
Granted Patent B2
US 7,482,426 · App. 10/246,983 · Granted Jan 27, 2009

C23 Polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,482,426
App. No.
10/246,983
Granted
Jan 27, 2009
Kind
B2
Abstract

Nucleic acids encoding a new family of small cysteine rich soluble proteins, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.

Claims (9)

1. An isolated polypeptide comprising the sequence of residues 1 to 90 of SEQ ID NO: 2.

2. The isolated polypeptide of claim 1 comprising the sequence of residues −18 to 90 of SEQ ID NO: 2.

3. A composition comprising the isolated polypeptide of claim 1 and a carrier, wherein said carrier comprises water, saline, or buffer.

4. A composition comprising the isolated polypeptide of claim 1 and a carrier, wherein said carrier is formulated for oral, rectal, nasal, topical, or parenteral administration.

5. The isolated polypeptide of claim 1 further comprising a detection or purification tag.

6. A kit comprising:

a) the isolated polypeptide of claim 1 ; and

b) instructions for use of the polypeptide.

7. An isolated polypeptide comprising the sequence of residues 33 to 86 of SEQ ID NO: 2.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →